Repair of acute respiratory distress syndrome by stromal cell administration (REALIST) trial: A phase 1 trial

BACKGROUND: Mesenchymal stromal cells (MSCs) may be of benefit in acute respiratory distress syndrome (ARDS) due to immunomodulatory, reparative, and antimicrobial actions. ORBCEL-C is a population of CD362 enriched umbilical cord-derived MSCs. The REALIST phase 1 trial investigated the safety and f...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorman, Ellen, Shankar-Hari, Manu, Hopkins, Phil, Tunnicliffe, William S., Perkins, Gavin D., Silversides, Jonathan, McGuigan, Peter, Krasnodembskaya, Anna, Jackson, Colette, Boyle, Roisin, McFerran, Jamie, McDowell, Cliona, Campbell, Christina, McFarland, Margaret, Smythe, Jon, Thompson, Jacqui, Williams, Barry, Curley, Gerard, Laffey, John G., Clarke, Mike, McAuley, Daniel F., O'Kane, Cecilia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551601/
https://www.ncbi.nlm.nih.gov/pubmed/34746723
http://dx.doi.org/10.1016/j.eclinm.2021.101167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551601/
https://www.ncbi.nlm.nih.gov/pubmed/34746723
http://dx.doi.org/10.1016/j.eclinm.2021.101167

Ejemplares similares